Life Sciences Maste Perceptive's Net Worth
Life Sciences Maste Perceptive's net worth is estimated to be at least $236,646,034.22 as of 12/22/2024. CoreStreet's estimation of Life Sciences Maste Perceptive's net worth is based on their sale of stock and current holding of stock.
Life Sciences Maste Perceptive is Major Shareholder at Albireo Pharma Inc. They have executed at least 30 trades of stock as per SEC Form 4 filings. Their most recent trade was for 400,000 units of ALBO stock on 09/14/2020. Their biggest sale was on 06/19/2017 when they sold 875,000 units of AcelRx Pharmaceuticals Inc stock for $2,100,000.00. They typically trade 7 times per year.
Total value of insider buys:
- $234,456,445.82
Total value of insider sells:
- $2,189,588.40
Most recent insider trade:
- Sept. 14, 2020
Life Sciences Maste Perceptive's Insider Trading History
| Albireo Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 14, 2020 | Major Shareholder | 400,000 | $40.00 | Buy | $16,000,000.00 |
Jan. 25, 2018 | Major Shareholder | 275,000 | $33.00 | Buy | $9,075,000.00 |
| VBI Vaccines Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 24, 2020 | Major Shareholder | 9,090,909 | $1.21 | Buy | $10,999,999.89 |
June 17, 2019 | Major Shareholder | 1,000,000 | $0.62 | Buy | $620,000.00 |
Oct. 26, 2017 | Major Shareholder | 3,100,000 | $3.05 | Buy | $9,455,000.00 |
| Agile Thrpe | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 25, 2020 | Major Shareholder | 3,000,000 | $3.02 | Buy | $9,060,000.00 |
July 26, 2018 | Insider | 298,628 | $0.30 | Sell | $89,588.40 |
| Athenex Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 23, 2019 | Major Shareholder | 606,302 | $14.54 | Buy | $8,815,631.08 |
Aug. 8, 2019 | Major Shareholder | 808,481 | $14.67 | Buy | $11,860,416.27 |
June 17, 2019 | Major Shareholder | 130,000 | $17.94 | Buy | $2,332,200.00 |
June 13, 2019 | Major Shareholder | 75,710 | $17.05 | Buy | $1,290,855.50 |
| MeiraGTx Holdings PLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 12, 2019 | Director | 425,531 | $23.50 | Buy | $9,999,978.50 |
March 1, 2019 | Major Shareholder | 1,304,348 | $13.80 | Buy | $18,000,002.40 |
June 12, 2018 | Director | 1,383,333 | $15.01 | Buy | $20,763,828.33 |
| Solid Biosciences LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 25, 2019 | Director | 2,822,581 | $4.65 | Buy | $13,125,001.65 |
Jan. 30, 2018 | Director | 1,020,000 | $16.22 | Buy | $16,544,400.00 |
| Motus GI Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2019 | Major Shareholder | 1,000,000 | $3.00 | Buy | $3,000,000.00 |
Feb. 16, 2018 | Major Shareholder | 1,000,000 | $5.00 | Buy | $5,000,000.00 |
| ADMA Biologics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 21, 2019 | Major Shareholder | 4,000,000 | $4.00 | Buy | $16,000,000.00 |
| Quotient Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 7, 2018 | Major Shareholder | 2,000,000 | $6.50 | Buy | $13,000,000.00 |
May 23, 2018 | Major Shareholder | 450,000 | $6.45 | Buy | $2,902,500.00 |
| Amicus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 3, 2018 | Major Shareholder | 50,000 | $12.59 | Buy | $629,500.00 |
Sept. 21, 2018 | Major Shareholder | 50,000 | $12.53 | Buy | $626,500.00 |
Sept. 12, 2018 | Major Shareholder | 500,000 | $12.00 | Buy | $6,000,000.00 |
March 1, 2018 | Major Shareholder | 100,000 | $13.69 | Buy | $1,369,000.00 |
July 13, 2017 | Major Shareholder | 1,500,000 | $12.25 | Buy | $18,375,000.00 |
| Crinetics Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 20, 2018 | Director | 400,000 | $17.00 | Buy | $6,800,000.00 |
| Aldeyra The | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 19, 2017 | Major Shareholder | 200,000 | $7.25 | Buy | $1,450,000.00 |
June 30, 2017 | Major Shareholder | 296,007 | $4.60 | Buy | $1,361,632.20 |
| AcelRx Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 19, 2017 | Major Shareholder | 875,000 | $2.40 | Sell | $2,100,000.00 |